Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Any congenital myasthenic syndrome in which the cause of the disease is a mutation in the SNAP25 gene.
Features include always present findings: Poor speech, Echolalia, Difficulty walking (gait disturbance), and Delayed ability to walk and others.
Organ System | Phenotype Count | Example Features |
|---|---|---|
Brain and nerves | 5 | Poor speech, Difficulty walking (gait disturbance), Dysarthria |
Muscles | 2 | Fatigable weakness, Knee flexion contracture |
Pregnancy and birth | 2 | Decreased fetal movement, Neonatal respiratory distress |
Eyes | 1 | Ptosis |
Lungs and breathing | 1 | Neonatal respiratory distress |
SNAP25 function has not been fully characterized.
Congenital myasthenic syndrome 18 is associated with mutations in the SNAP25 gene on chromosome 20.
Genetic testing for SNAP25 is available. Testing is considered confirmatory for diagnosis.
Biomarker and diagnostic research for congenital myasthenic syndrome 18 has been reported in the published literature.
Phenotype severity distribution: 13 always present features.
No clinical trials have been registered for congenital myasthenic syndrome 18.
17 publications have been identified in PubMed for congenital myasthenic syndrome 18. Research spans Epidemiology / Natural History (29%), Review / Meta-Analysis (18%), and Case Report / Case Series (18%).
Research Type | Count | % of Total |
|---|---|---|
Disease patterns and progression | 5 | 29% |
Research summaries | 3 | 18% |
Patient case studies | 3 | 18% |
Testing and diagnosis research | 2 | 12% |
Laboratory research | 2 | 12% |
Clinical study results | 1 | 6% |
New treatment approaches | 1 | 6% |
Akçay AA (2026). [PMID: 41451794](https://pubmed.ncbi.nlm.nih.gov/41451794/). *Clin Genet*. [Basic Science / Preclinical]
Wang T (2026). [PMID: 41547082](https://pubmed.ncbi.nlm.nih.gov/41547082/). *Pediatr Neurol*. [Clinical Trial Publication]
Akiyama M (2025). [PMID: 39913008](https://pubmed.ncbi.nlm.nih.gov/39913008/). *CEN Case Rep*. [Case Report / Case Series]
Ohno K (2025). [PMID: 40533459](https://pubmed.ncbi.nlm.nih.gov/40533459/). *J Hum Genet*. [Review / Meta-Analysis]
Della Marina A (2025). [PMID: 39948634](https://pubmed.ncbi.nlm.nih.gov/39948634/). *Acta Neuropathol Commun*. [Diagnostic / Biomarker]
Yeung TMH (2025). [PMID: 41362569](https://pubmed.ncbi.nlm.nih.gov/41362569/). *Cureus*. [Case Report / Case Series]
Zhang J (2025). [PMID: 40442802](https://pubmed.ncbi.nlm.nih.gov/40442802/). *Orphanet J Rare Dis*. [Epidemiology / Natural History]
Prodromos CC (2025). [PMID: 41278139](https://pubmed.ncbi.nlm.nih.gov/41278139/). *Am J Stem Cells*. [Gene Therapy / Novel Therapeutics]
Takhman M (2025). [PMID: 41382066](https://pubmed.ncbi.nlm.nih.gov/41382066/). *BMC Neurol*. [Review / Meta-Analysis]
Krenn M (2025). [PMID: 41004697](https://pubmed.ncbi.nlm.nih.gov/41004697/). *Neurology*. [Diagnostic / Biomarker]
Data assembled from 5 of 12 sources · Last updated Sep 20, 2026, 12:21 PM UTC
Patient Advocacy Groups (PAGs) provide support, resources, and community for patients and caregivers.
Online Mendelian Inheritance in Man
Genetic and Rare Diseases Info Center
AI-curated news mentioning congenital myasthenic syndrome 18
Updated Aug 27, 2026
A recent study highlights the clinical variability and genotype-driven outcomes in CHRND-related congenital myasthenic syndrome. This research provides insights into how different genetic mutations can influence disease presentation and patient management.